Recall Enforment Report D-0487-2024

Recall Details

Drug Recall Enforcement Report Class II voluntary initiated by Rubicon Research Private Limited, originally initiated on 04-26-2024 for the product traMADol Hydrochloride Tablets, USP 50 mg, 1000-count bottle, Rx Only, Distributed by: Advagen Pharma Limited, 666 Plainsboro Road Suite 605, Plainsboro, NJ, 08536, USA, Manufactured by: Rubicon Research, Private Limited, Ambernath, Dist. Thane, 421506 India NDC 72888-080-00 The product was recalled due to presence of foreign tablets: pharmacist reported a tablet of baclofen in a bottle of 1000-count tramadol. The product was distributed nationwide and the recall is currently ongoing.

Field Name Field Value
Event ID 94467 What is the Event ID?
A numerical designation assigned by FDA to a specific recall event (used for tracking purposes).
Recall Number D-0487-2024 What is the Recall Number?
An alphanumeric designation assigned by FDA to a specific, classified recalled product (used for tracking purposes).
Recall Classification Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote What is the Recall Classification?
Numerical designation (I, II, or III) that is assigned by FDA to a particular product recall that indicates the relative degree of health hazard. For recalls pending classification, the entry will display as "Not Yet Classified".
Distribution Pattern Nationwide in the USA What is the Distribution Pattern?
General area of initial distribution such as states, countries, or territories. Note that subsequent distribution by the consignees to other parties may not be included.
Product Description traMADol Hydrochloride Tablets, USP 50 mg, 1000-count bottle, Rx Only, Distributed by: Advagen Pharma Limited, 666 Plainsboro Road Suite 605, Plainsboro, NJ, 08536, USA, Manufactured by: Rubicon Research, Private Limited, Ambernath, Dist. Thane, 421506 India NDC 72888-080-00
Reason For Recall Presence of Foreign Tablets: Pharmacist reported a tablet of baclofen in a bottle of 1000-count tramadol What is the Reason for Recall?
Information describing how the product is defective.
Product Quantity 2,592 1000-count Bottles Product Quantity
The amount of product subject to recall.
Voluntary Mandated Voluntary: Firm initiated Voluntary / Mandated
Designates that a recall was initiated voluntarily by a firm on its own volition or after being requested to recall by FDA. “Mandatory” designates that a recall was initiated under a mandatory (statutory) recall authority, a court order, or FDA order.
Report Date 05-15-2024
Recall Initiation Date 04-26-2024 What is the Recall Initiation Date?
The date that the firm first began notifying the public or their consignees of the recall.
Initial Firm Notification Letter Initial Firm Notification of Consignee or Public
The method(s) by which the firm initially notified the public or their consignees of a recall.
Product Type Drugs
Recalling Firm Rubicon Research Private Limited
Code Info Lot #: 230774Hl, Exp 4/30/2026 Code Information
A list of all lot and/or serial numbers, product numbers, expiration dates, sell or use by dates, etc., which appear on the product or its labeling.
Recalled NDC Packages 72888-162-30; 72888-162-01; 72888-162-05; 72888-162-00; 72888-080-01; 72888-080-05; 72888-080-00; 72888-008-01; 72888-008-05; 72888-008-00
Status Ongoing

Recalled Products

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Product Type
72888-008Tramadol Hydrochloride Tramadol HydrochlorideTablet, CoatedOralAdvagen Pharma LimitedHuman Prescription Drug
72888-080Tramadol Hydrochloride Tramadol HydrochlorideTablet, CoatedOralAdvagen Pharma LimitedHuman Prescription Drug
72888-162Tramadol Hydrochloride Tramadol HydrochlorideTablet, CoatedOralAdvagen Pharma LimitedHuman Prescription Drug